Current glucose reading
Guide patients’ CGM journey with FreeStyle Libre systems.
Find the tools and information you need to confidently counsel and support patients using Libre systems.
CGM = continuous glucose monitor(ing)
Libre has you covered*†1.
Through insurance or Abbott support*†1. Recommend the most affordable CGM with the Libre 3 system‡1. More savings. More confidence. Less frustration.
Help patients access the Libre 3 Plus sensor, the world’s smallest, thinnest§1 15-day sensor—right at the pharmacy counter.
Helping patients get a more affordable price||¶1, right at the register with a savings card.
Savings cards help commercially insured and uninsured patients save money on their FreeStyle Libre systems prescriptions¶.
Need help with a savings card or patient purchase? Call the pharmacist help line at 855-201-9663.
GLP-1 = glucagon-like peptide-1
See why pharmacists recommend the Libre 3 Plus sensor.
Libre systems can support patients by enhancing self-management, driving positive behavior change, and improved glycemic outcomes2.
Proven to significantly lower A1C**††3
Patients with T2D on non-insulin therapy report a 1.6% reduction of A1C at 6 months**††3.
GLP-1 therapy users can expect additional A1C reductions‡‡4
Patients experienced significant reductions in A1C after using Libre systems‡‡4.
Patients spend less time in hypoglycemia§§5
T2D patients also saw 43% less time spent in hypoglycemia—with no increase in A1C§§5.
T2D = type 2 diabetes
Discover Libre, the only CGM technology that connects to all leading pump brands in the US1.
The Libre 3 Plus and Libre 2 Plus sensors are the first and only1 15-day sensors for all ages (2+)6,7. They are proven to be accurate6,7 and comfortable to wear8.
Libre app¶¶: Insights, a tap away
Designed to make it even easier## to see their glucose levels
Real-time glucose information
Trend arrow
Glucose history
Sensor life span
App¶¶ users achieved better glucose control and spent more time in range compared with reader users***9.
Personalized food suggestions†††
Only Libre has Libre Assist‡‡‡.
Libre Assist‡‡‡ is a free feature in the Libre app¶¶ designed to support behavioral dietary change.
Help patients download the free Libre app¶¶ to their smartphone today.
Ongoing support for you and patients§§§
Get practical resources designed to support you and patients at every step.
Free one-on-one training with a Certified Diabetes Care and Education Specialist.
Get our one-pager with the resources patients need to make the most of the Libre systems.
Get more information on dispensing and recommending the Libre systems, including ordering and fulfillment details.
Questions? Contact our customer care team at 855-632-8658.
Need to replace a CGM for a patient? Learn more about our replacement program.
Thank you for joining.
Thank you for joining.
We look forward to keeping you informed with our latest news and updates.
Customer Care Team
Contact our care team for more information
and to speak directly to a customer service
representative.
Pharmacist Toolkit
All you need to know to dispense and recommend
the FreeStyle Libre 3 Plus sensor, including
ordering and filling information and FAQs.
Discover which product is right for patients.
We regret to inform you that we’ve had some difficulty processing your request. To further assist you, please contact the Support Team
The FreeStyle Libre 3 system includes the Libre 3 Plus sensor, Libre 3 sensor, Libre 3 app, Libre app, and the Libre 3 reader.
The FreeStyle Libre 2 system includes the Libre 2 Plus sensor, Libre 2 sensor, Libre 2 app, Libre app, and the Libre 2 reader.
FreeStyle Libre 3 system is cleared to be used by children 4 years and older with Libre 3 sensor and 2 years and older with Libre 3 Plus sensor.
FreeStyle Libre 2 system is cleared to be used by children 4 years and older with Libre 2 sensor and 2 years and older with Libre 2 Plus sensor.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
* Based on prescription claims for commercially insured and uninsured patients using the FreeStyle Libre personal CGM systems. May not include Medicare, Medicaid, and other federal or state healthcare program patients. The actual amount a patient pays may vary. The FreeStyle Libre 3 system requires a prescription.
† Benefits apply to FreeStyle Libre 3 sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
‡ Based on pharmacy claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus Dexcom CGM systems. Does not include fee-for-service Medicare or fee-for-service Medicaid. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
§ Among patient-applied sensors.
|| Based on prescription claims for commercially insured and uninsured patients using the FreeStyle Libre personal CGM systems. Does not include Medicare, Medicaid, and other federal or state healthcare program patients. The actual amount a patient pays may vary. The FreeStyle Libre personal CGM systems require a prescription.
¶ Benefits apply to FreeStyle Libre personal CGM sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
** Study was performed with the US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and 2 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
†† Retrospective observational study with average baseline A1C 10.1% ± 1.7%.
‡‡ Real-world analysis of changes in A1C with the addition of FreeStyle Libre systems among adults with T2D currently using GLP-1 therapy (N=1,454).
§§ Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 system, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
¶¶ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
## The Libre app works with Libre 2, Libre 2 Plus, Libre 3 and Libre 3 Plus sensors and glucose data updates automatically without scanning the sensor.
*** The FreeStyle Libre systems apps and the FreeStyle Libre systems readers have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
††† Personalized food suggestions are based on food preference information inputted by the user.
‡‡‡ Libre Assist is a feature within Libre app that uses generative artificial intelligence to provide information on how foods could impact your glucose levels. Generative artificial intelligence may not always be accurate, and it should not be used to make treatment decisions.
§§§ Abbott Diabetes Care offers patient and practice support through Customer Support, MyFreeStyle program, and FreeStyle Foundations.
References: 1. Data on file. Abbott Diabetes Care, Inc. 2. Polonsky, William H., et al. "Does Continuous Glucose Monitoring Use Prompt Greater Engagement in Self-Management? A Randomized Controlled Trial Focusing on Adults with Type 2 Diabetes." Journal of Diabetes Science and Technology (2025). https://doi.org/10.1177/19322968251361031. 3. Wright, Eugene E. Jr., et al. “Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.” Diabetes Spectrum 34, no. 2 (2021): 184–189. ds200069. https://doi.org/10.2337/ds20-0069. 4. Miller, Eden, et al. “Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People With Sub‐optimally Treated Type 2 Diabetes Taking GLP‐1 RA Therapy.” Diabetes Therapy 15 (2024): 2027–2038. https://doi.org/10.1007/s13300-024-01619-1. 5. Haak, Thomas, et al. “Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: A Multicentre, Open-Label Randomised Controlled Trial.” Diabetes Therapy 8 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 6. FreeStyle Libre 3 User’s Manual. 7. FreeStyle Libre 2 User's Manual. 8. Alva, Shridhara, et al. “Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.” Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 9. Kao, Kalvin, Laura Brandner, and Naunihal Virdi. “Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps.” Journal of Diabetes Science and Technology 16, no. 1 (2022): 259–260. https://doi.org/10.1177/19322968211044141.
ADC-2669305 v2.0
Important Safety Information
Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Get medical attention when appropriate. Abbott Customer Service at 855-632-8658 or visit FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-2688941 v26.0
